VEGFA and Alzheimer disease: XM-24 highly likely execute anti-AD effects by regulates PI3K-Akt signaling, Neuroactive ligand-receptor interaction and Rho signaling pathway, etc., whereas its active compounds of by interacting with STAT3, VEGFA, and MAPK3.